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ABSTRACT
Introduction: Laparoscopic adjustable gastric banding
(LAGB) is a reversible method of surgical gastric restric-
tion. Following LAGB, the adverse event most commonly
necessitating subsequent reoperation is prolapse of the
gastric corpus or fundus above the band. A review of the
medical literature reveals no reports of nonpancreatic
pseudocysts being associated with this adverse event.
Nonpancreatic pseudocysts, encountered during revi-
sional bariatric surgery should be considered a cause of
irreducible gastric prolapse.
Case Report: We report the case of a 41-year-old Cauca-
sian female who underwent laparoscopic surgery to revise
an adjustable gastric band and to repair an anterior gastric
prolapse. Intraoperatively, 2 pseudocysts were found on
the gastric fundus above the band in association with the
gastric prolapse. The pseudocysts were resected, the gas-
tric prolapse was reduced, and the band was left in place.
The patient recovered uneventfully.
Conclusion: Nonpancreatic pseudocysts may be associ-
ated with gastric prolapse in patients who have under-
gone LAGB. These pseudocysts can often be excised lapa-
roscopically without violating the gastric lumen. This
atypical presentation of gastric prolapse may pose a diag-
nostic and therapeutic challenge as these patients may
present to an outpatient clinic or emergency room with
nonspecific symptoms.
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INTRODUCTION
Laparoscopic adjustable gastric banding (LAGB) is a pop-
ular bariatric surgery (300,000 performed worldwide
from 2001 to 20071), which is indicated for weight reduc-
tion in severely obese patients. The adjustable gastric
band was approved by the United States Food and Drug
Administration (FDA) in June 2001, for patients who have
failed trials of medical weight loss, and who have a body
mass index (BMI) 40kg/m
2,o raB M I35kg/m
2 with
one or more severe comorbidities, or weigh 100 pounds
above their estimated ideal body weight.2 Once inserted,
the device creates a restricted gastric opening and a small
gastric pouch that limits food consumption and promotes
early satiety.
Although band placement has the advantage of being
adjustable and reversible when compared to other bariat-
ric surgeries, LAGB has been associated with adverse
events in the acute and long-term settings.3 As reported by
the FDA, during the course of the LAP-BAND System US
clinical trial (1997 through 2001), 89% of the 299 subjects
reported at least one adverse event. The most commonly
reported events were nausea/vomiting (51%), gastro-
esophageal (GE) reflux (34%), abdominal pain (27%),
band slippage/pouch dilation (24%), stoma obstruction
(14%), and dysphagia (9%). At 3 years, 9% of the 299
subjects had subsequently required revision surgery of
their gastric band.2 These trends were further character-
ized by Mittermair et al in 2009, when it was reported that
of 733 LAGB patients who completed a 10-year follow-up
in Sweden, 50.4% of these patients reported at least one
complication and 32% required revision surgery.4
Gastric prolapse and/or band slippage is the most com-
mon complication of LAGB necessitating reoperation.5 It
is often due to improper surgical fixation, premature re-
introduction of solid food postoperatively, excessive band
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CASE REPORTinflation, or recurrent vomiting. Gastric prolapse can rep-
resent a surgical emergency, which has been associated
with cases of gastric necrosis, obstruction, esophageal or
gastric dilatation with perforation, malnutrition, and de-
hydration.5 Gastric prolapse poses a diagnostic challenge
for both surgeons and nonsurgeons, because the symp-
toms are often nonspecific. In a review of gastric prolapse-
related events, pseudocyst development on the gastric
wall has not been previously described. As such, the
potential of pseudocyst formation as a complication of
LAGB needs to be further characterized and evaluated.
The purpose of this case report is to document this ad-
verse event, so that future occurrences can help to clarify
any confounding factors, predisposed patient population,
and treatment of choice.
CASE REPORT
History
In October 2009, a 41-year-old Caucasian female with a
history of Class II Obesity, hypertension, hypercholester-
olemia, obstructive sleep apnea, gastroesophageal reflux
disease, and depression, presented 18 months after un-
dergoing LAGB. The LAP-BAND Advanced Platform (AP)
System standard band was placed via the pars flaccida (PF)
technique with the position confirmed by a postoperative
upper GI series. At this presentation, she developed symp-
toms of persistent dysphagia, nausea, vomiting, regurgita-
tion, and failure to thrive with 3.2mL of saline in her band
(BMI22.1kg/m
2, down from 35.8kg/m
2 at initial opera-
tion). Although the patient had been properly educated on
food portion size and follow-up procedure, she was non-
compliant. She experienced episodic vomiting and regurgi-
tation from ingesting large food portions. A routine, single
contrast upper GI barium series showed, severe gastro-
esophageal (GE) reflux and delayed emptying through the
gastric band. A significant portion of the gastric fundus was
found above the band, strongly indicative of a gastric
prolapse. There were no strictures, ulcerations, or dilata-
tion of the esophagus. EGD was remarkable for Grade II
erosive reflux-induced esophagitis, but the gastric pro-
lapse was not appreciated. The patient was informed of
the band slippage and the need for surgical intervention.
However, she declined to have the surgery at this time.
The remaining saline was removed from the band but her
symptoms failed to resolve. Three months later, the pa-
tient consented to surgery.
Operative Report (January 2010)
Using a laparoscopic approach, the gastric prolapse could
not be reduced despite the freeing of multiple dense adhe-
sions around the band and the gastric pouch (Figure 1).
We discovered 2 moderately firm masses on the gastric
pouch above the band, which were initially thought to be
bezoars. These masses prevented the reduction of the
gastric fundus (Figure 2). Intraoperative endoscopy was
performed. The gastric mucosa appeared normal with no
evidence of ischemia. No apparent connection was found
between the lumen of the pouch and the masses. After
careful inspection, we concluded that these masses were
Figure 1. Initial laparoscopic view of gastric band (white arrow),
demonstrating prolapse with associated mass (blue arrowhead).
Figure 2. After opening the gastric band (white arrow) and
freeing the stomach of adhesions, a 4.4x3.6x3.0-cm fundal
pseudocyst (blue arrowheads) is clearly visible.
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masses was pedunculated and was connected to the gas-
tric wall via a broad stalk (Figure 3). Resection of the
mass was performed using a linear stapler. The specimen
was removed and inspected. It appeared to be cystic in
nature. Incision into the mass was performed, which pro-
duced a clear serous fluid. The fluid did not appear to be
infected, and the gram stain proved negative.
Satisfied that the cyst was not infected, we concluded that
the band could be safely left in place. The second cystic
mass had a wider base but was resected and removed in
a similar fashion. At no time was there any air leak or
bubbles from the insufflated stomach. The stomach was
then deflated, and the gastric prolapse could now be
completely reduced. Pathologic evaluation of the cysts
(4.4 x 3.6 x 3.0cm and 6.1 x 3.5 x 0.3cm) revealed fibrous
walls with acute and chronic inflammation, granulation
tissue, areas of necrosis, and no gastric mucosa. Postop-
eratively, the patient recovered remarkably well with res-
olution of dysphagia and vomiting.
DISCUSSION
Since the advent of LAGB, improved surgical techniques
have significantly reduced the frequency and severity of
early and late postoperative complications. The wide-
spread adoption of the pars flaccida (PF) technique of
band insertion, over the traditional perigastric (PG)
method, has significantly reduced the incidence of gastric
prolapse. Early reported incidences of gastric prolapse
following PG banding of 25%, have now been reduced
to 2% with the PF technique.6 However, due to a lack of
reported occurrences, it is difficult to determine whether
pseudocyst formation is more common following the PG
or the PF technique.
The majority of the gastric surface is covered with a
single layer of peritoneum, so it does not have the
intramembranous space that would predispose it to the
development of cysts. Nonpancreatic pseudocysts have
thick fibrous walls and lack epithelial lining, such as
those seen in our patient. These pseudocysts have been
further classified as being either infectious, traumatic,
or in rare cases degenerative. Their contents can be
chylous or serous, but more commonly are bloody or
purulent material. On cytological analysis, the wall
characteristically contains inflammation and granula-
tion tissue, with or without calcification or cellular ne-
crosis.7 Although, more often associated with either
blunt trauma or abscess formation, a few cases have
been associated with GI surgeries including partial gas-
trectomy, gastrojejunostomy, and pyloroplasty.8
What these surgeries may have in common with our
patient is that due to the trauma of the surgery or a
chronically malpositioned band, lymph channels draining
the stomach may become disrupted, resulting in a con-
fined extravasation of lymph and blood components,
causing a localized inflammatory response in susceptible
patients. A laparoscopic approach to excise a pseudocyst
is probably favorable, since it is likely to be encountered
as an incidental finding during laparoscopic gastric band
revision surgery. Extraluminal pseudocysts may be diffi-
cult to discern preoperatively with an upper gastrointes-
tinal (GI) series or esophagogastroduodenoscopy (EGD).
Therefore, abdominal ultrasound, nuclear imaging, com-
puted tomography, or magnetic resonance imaging may
be required for preoperative diagnosis.9 With our patient,
the pseudocysts were dissected and then enucleated with
a linear stapler due to their broad stalk-like base. How-
ever, because these pseudocysts are not infectious or
neoplastic, if there is a concern for hemorrhage or a
difficult excision, methods like marsupialization or fenes-
tration can be used.
In this case, the exact pathogenesis of these nonpancreatic
pseudocysts is unclear. They may have played a role in
the development of the gastric prolapse, but more likely
they were caused by the chronically slipped band in a
susceptible patient. We felt that reduction of the prolapse
in this patient was not possible until the cysts were re-
sected. There is currently no medical literature reporting the
Figure 3. Two pseudocysts (blue arrowheads) and their stalk-
like attachments (green stars) to the gastric fundus are visible
after blunt dissection and opening of the laparoscopic adjustable
gastric band (white arrow).
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tric wall and its associated visceral peritoneum. As such, it is
difficult to determine how often this adverse event occurs
with chronically slipped gastric bands and what the potential
complications of pseudocyst formation are.
CONCLUSION
We report a case of nonpancreatic pseudocysts being
associated with an anterior gastric prolapse following
LAGB. We also report the successful laparoscopic resec-
tion of these pseudocysts, and the subsequent reduction
of a previously irreducible anterior gastric prolapse. Fur-
ther data would be needed to define any causal relation-
ship between LAGB, nonpancreatic pseudocysts, gastric
prolapse, the surgical technique used, the type of band
used, and the time period of band slippage. Its incidental
finding as a potential cause of increased gastric restriction
and possible interference with spontaneous prolapse re-
duction has important diagnostic and surgical implica-
tions.
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